VIRMA and lung adenocarcinoma: High expression of KIAA1429 in lung adenocarcinoma increases the m6A level of the downstream target gene ARHGAP30, which leads to a decrease in the expression of ARHGAP30, thus contributing to lung adenocarcinoma progression.